Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases



Status:Available
Conditions:Prostate Cancer, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:18 - Any
Updated:3/1/2014
Contact:Bayer Clinical Trials Contact
Email:clinical-trials-contact@bayerhealthcare.com

Use our guide to learn which trials are right for you!

Radium-223 Chloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

This study is a prospective, interventional, open-label, multi-center early access program
for the use of Ra-223 Cl2 in HRPC/CRPC patients diagnosed with symptomatic bone metastasis
and to collect additional short and long term safety data on the product.


Inclusion Criteria:

- Age ≥ 18 years

- Histologically or cytologically confirmed prostate cancer

- Patients diagnosed with symptomatic progressive bone predominant metastatic CRPC/HRPC
with at least 2 skeletal metastases on imaging with no lung, liver, and/or brain
metastasis (lymph node only metastasis is allowed)

- Symptomatic is defined as either

- Regular (not occasional) use of analgesic medication for cancer related bone
pain (≥ level 1; World Health Organization [WHO] ladder for cancer pain), or

- Treatment with external beam radiation therapy (EBRT) for bone pain (the EBRT
should be within the last 12 weeks before treatment)

- Progressive disease is defined either by:

- The appearance of new bone lesions. If progression is based on new lesion(s) on
imaging only without an increase in prostate specific antigen (PSA), then PSA
values from 3 assessments within the last 6 months must be provided; OR

- In the absence of new bone lesions, 2 subsequent increases in serum PSA over
previous reference value, which should not be more than 6 months before
screening, each measured at least 1 week apart with the last PSA ≥ 5 ng/mL.
(The reference value time point 1, is defined as the last PSA measured before
increases are documented, with subsequent values obtained a minimum of 1 week
apart. If the PSA at time point 3 is greater than the PSA at time point 2, then
eligibility has been met. If the PSA at time point 3 is not greater than the PSA
at time point 2 but, the PSA value at time point 4 and/or time point 5 is
greater than the PSA at time point 2, the patient is eligible assuming that
other criteria are met).

- No intention to use cytotoxic chemotherapy within the next 6 months

- Life expectancy ≥ 6 months

- Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0-2

- Adequate hematological, liver, and renal function

- Absolute neutrophil count (ANC) ≥ 1.5 x10^9/L

- Platelet count ≥ 100 x10^9/L

- Hemoglobin ≥ 10.0 g/dL (100 g/L; 6.2 mmol/L)

- Total bilirubin level ≤ 1.5 x institutional upper limit of normal (ULN)

- Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 2.5 x ULN

- Creatinine ≤ 1.5 x ULN

- Albumin > 25 g/L *Any bone imaging techniques as per institutional standard of
care

Exclusion Criteria:

- Treatment with an investigational drug within previous 4 weeks, or planned during the
treatment period or follow-up

- Eligible for first course of docetaxel, i.e., patients who are fit enough, willing,
and who are located where treatment with docetaxel is available

- Treatment with cytotoxic chemotherapy within previous 4 weeks prior to screening, or
failure to recover from adverse events (AEs) due to cytotoxic chemotherapy
administered more than 4 weeks previous prior to screening (however, ongoing
neuropathy is permitted)

- Prior hemibody external radiotherapy is excluded. Patients who received other types
of prior external radiotherapy are allowed provided that the bone marrow function is
assessed and meets the protocol requirements for hemoglobin, absolute neutrophil
count, and platelets

- Received systemic therapy with radionuclides (e.g., strontium-89, samarium-153,
rhenium-186, or rhenium-188, or radium-223 dichloride) for the treatment of bony
metastases

- Other malignancy treated within the last 3 years (except non melanoma skin cancer or
low-grade superficial bladder cancer)

- Visceral metastases as assessed by abdominal or pelvic computed tomography (CT) (or
other imaging modality based on institutional standard of care)

- Presence of brain metastases

- Lymphadenopathy exceeding 6 cm in short-axis diameter

- Any size pelvic lymphadenopathy if it is thought to be a contributor to concurrent
hydronephrosis.

- Imminent spinal cord compression based on clinical findings and/or magnetic resonance
imaging (MRI). Patients with history of spinal cord compression should have
completely recovered.

- Any other serious illness or medical condition, such as but not limited to:

- Any infection ≥ National Cancer Institute Common Terminology Criteria for
Adverse Events (NCI-CTCAE) version 4.03 Grade 2

- Cardiac Failure New York Heart Association (NYHA) Class III or IV

- Crohn's disease or ulcerative colitis

- Bone marrow dysplasia

- Fecal incontinence
We found this trial at
58
sites
?
mi
from
Stanford, CA
Click here to add this to my saved trials
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Aurora, CO
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Bethesda, MD
Click here to add this to my saved trials
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Columbus, OH
Click here to add this to my saved trials
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
Fort Myers, FL
Click here to add this to my saved trials
?
mi
from
Goshen, IN
Click here to add this to my saved trials
?
mi
from
Greenbrae, CA
Click here to add this to my saved trials
?
mi
from
Hampton, VA
Click here to add this to my saved trials
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Iowa City, IA
Click here to add this to my saved trials
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
?
mi
from
Miami Beach, FL
Click here to add this to my saved trials
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Myrtle Beach, South Carolina 29572
?
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Myrtle Beach, South Carolina 29572
?
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
New Brunswick, New Jersey 08901
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Newark, DE
Click here to add this to my saved trials
?
mi
from
Newark, NJ
Click here to add this to my saved trials
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
?
mi
from
Plano, TX
Click here to add this to my saved trials
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
?
mi
from
Rockville, MD
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
?
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
?
mi
from
Seattle, WA
Click here to add this to my saved trials
?
mi
from
Springfield, OR
Click here to add this to my saved trials
?
mi
from
St. Louis, MO
Click here to add this to my saved trials
?
mi
from
Syracuse, NY
Click here to add this to my saved trials
?
mi
from
Tampa, FL
Click here to add this to my saved trials
?
mi
from
Temple, TX
Click here to add this to my saved trials
?
mi
from
Washington,
Click here to add this to my saved trials
?
mi
from
Washington,
Click here to add this to my saved trials
?
mi
from
Wheeling, WV
Click here to add this to my saved trials